Research graph
References from Unravelling neuroinflammation-mediated mitochondrial dysfunction in mild cognitive impairment: Insights from targeted metabolomics. Local targets link to admitted publications; unresolved targets remain external evidence.
Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease
10.2174/138161210793176572 · 2010 · External reference
Plasma amino acids metabolomics' important in glucose management in type 2 diabetes
10.3389/fphar.2021.695418 · 2021 · External reference
Impaired hippocampal glutamate and glutamine metabolism in the db/db mouse model of Type 2 diabetes mellitus
10.1155/2017/2107084 · 2017 · External reference
Metabolomics of type 1 and type 2 diabetes
10.3390/ijms20102467 · 2019 · External reference
Targeted NMR-based serum metabolic profiling of serine, glycine and methionine in acute-on-chronic liver failure patients: possible insights into mitochondrial dysfunction
10.1002/ansa.202000167 · 2021 · External reference
Chronic hyperprolinemia provokes a memory deficit in the Morris water maze task
10.1007/s11011-005-2478-x · 2005 · External reference
Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimers disease patients
10.3389/fnagi.2023.1219718 · 2023 · External reference
Energy metabolism decline in the aging brain-Pathogenesis of neurodegenerative disorders
10.3390/metabo10110450 · 2020 · External reference
Glutamine metabolism in diseases associated with mitochondrial dysfunction
10.1016/j.mcn.2023.103887 · 2023 · External reference
Proline oxidase controls proline, glutamate, and glutamine cellular concentrations in a U87 glioblastoma cell line
10.1371/journal.pone.0196283 · 2018 · External reference
Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism
10.1038/s41598-018-20834-y · 2018 · External reference
Diabetes-Alzheimer's disease link: targeting mitochondrial dysfunction and redox imbalance
10.1089/ars.2020.8056 · 2021 · External reference
Metabolic defects shared by Alzheimer's disease and diabetes: a focus on mitochondria
10.1016/j.conb.2023.102694 · 2023 · External reference
Glutamate and mitochondria: two prominent players in the oxidative stress-induced neurodegeneration
10.2174/1567205013666151218132725 · 2016 · External reference
Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults
10.1111/jnc.15128 · 2021 · External reference
Blood neuroexosomal mitochondrial proteins predict Alzheimer disease in diabetes
10.2337/db21-0969 · 2022 · External reference
Cytosolic accumulation of L-proline disrupts GABA-ergic transmission through GAD blockade
10.1016/j.celrep.2016.09.029 · 2016 · External reference
Nicotinamide as potential biomarker for Alzheimers disease: A translational study based on metabolomics
10.3389/fmolb.2022.1067296 · 2023 · External reference
Blood biomarkers indicate that the preclinical stages of Alzheimer's disease present overlapping molecular features
10.1038/s41598-020-71832-y · 2020 · External reference
Serum metabolite markers of dementia through quantitative NMR analysis: the importance of threonine-linked metabolic pathways
10.3233/jad-181189 · 2019 · External reference
Oxidative stress, neuroinflammation, and NADPH oxidase: implications in the pathogenesis and treatment of Alzheimer's disease
10.1155/2021/7086512 · 2021 · External reference
Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases
10.1016/j.bbadis.2009.08.010 · 2010 · External reference
Astrocyte mitochondria: Central players and potential therapeutic targets for neurodegenerative diseases and injury
10.1016/j.arr.2020.101039 · 2020 · External reference
Mitochondrial dysfunction and biogenesis in neurodegenerative diseases: pathogenesis and treatment
10.1111/cns.12655 · 2017 · External reference
Effect of ghrelin on serum metabolites in Alzheimer's disease model rats; a metabolomics studies based on 1H NMR technique
2018 · External reference
1H NMR metabolomics investigation of an Alzheimers disease (AD) mouse model pinpoints important biochemical disturbances in brain and plasma
10.1007/s11306-013-0516-y · 2013 · External reference
Metabolic signatures of human Alzheimers disease (AD): 1H NMR analysis of the polar metabolome of post-mortem brain tissue
10.1007/s11306-013-0610-1 · 2014 · External reference
Progression of Alzheimer's disease and effect of scFv-h3D6 immunotherapy in the 3xTg-AD mouse model: an in vivo longitudinal study using Magnetic Resonance Imaging and Spectroscopy
10.1002/nbm.4263 · 2020 · External reference
Nuclear magnetic resonance-based metabolomics approach revealed the intervention effect of using complementary and alternative medicine (CAM) by CKD Patients
10.1021/acsomega.2c06469 · 2023 · External reference
Metabolomics in diabetes and diabetic complications: insights from epidemiological studies
10.3390/cells10112832 · 2021 · External reference
Activation of proline biosynthesis is critical to maintain glutamate homeostasis during acute methamphetamine exposure
10.1038/s41598-020-80917-7 · 2021 · External reference
Is Alzheimer's disease a type 3 diabetes? A critical appraisal
10.1016/j.bbadis.2016.08.018 · 2017 · External reference
Metabolism-centric overview of the pathogenesis of Alzheimer's disease
10.3349/ymj.2017.58.3.479 · 2017 · External reference
Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome
10.1038/emm.2015.3 · 2015 · External reference
Metabolomic signatures in peripheral blood associated with Alzheimer's disease amyloid-induced neuroinflammation
10.3233/jad-132165 · 2014 · External reference
Circulatory glutamine/glucose ratio for evaluating disease activity in Takayasu arteritis: a NMR based serum metabolomics study
10.1016/j.jpba.2019.113080 · 2020 · External reference
Circulatory histidine levels as predictive indicators of disease activity in takayasu arteritis
10.1002/ansa.202000181 · 2021 · External reference
An elaborative NMR based plasma metabolomics study revealed metabolic derangements in patients with mild cognitive impairment: a study on north Indian population
10.1007/s11011-021-00700-z · 2021 · External reference
Elevated circulatory proline to glutamine ratio (PQR) in endometriosis and its potential as a diagnostic biomarker
10.1021/acsomega.2c00332 · 2022 · External reference
1H NMR metabolomic signatures in five brain regions of the APPswe Tg2576 mouse model of Alzheimer's disease at four ages
10.3233/jad-130023 · 2014 · External reference
Prevalence, influence factors and cognitive characteristics of mild cognitive impairment in type 2 diabetes mellitus
10.3389/fnagi.2019.00180 · 2019 · External reference
Mechanisms underlying the pathophysiology of type 2 diabetes: From risk factors to oxidative stress, metabolic dysfunction, and hyperglycemia
10.1016/j.mrgentox.2021.503437 · 2022 · External reference
Interplay between Alzheimers disease and global glucose metabolism revealed by the metabolic profile alterations of pancreatic tissue and serum in APP/PS1 transgenic mice
10.1038/s41401-019-0239-3 · 2019 · External reference
Crosstalk among disrupted glutamatergic and cholinergic homeostasis and inflammatory response in mechanisms elicited by proline in astrocytes
10.1007/s12035-014-9067-0 · 2016 · External reference
Glial mitochondrial function and dysfunction in health and neurodegeneration
10.1016/j.mcn.2019.103417 · 2019 · External reference
Type 3 diabetes is sporadic Alzheimer's disease: mini-review
10.1016/j.euroneuro.2014.06.008 · 2014 · External reference
Oxidative stress and antioxidant defenses in mild cognitive impairment: a systematic review and meta-analysis
10.1016/j.arr.2022.101639 · 2022 · External reference
Characterising Alzheimer's disease through integrative NMR-and LC-MS-based metabolomics
10.1016/j.metop.2021.100125 · 2021 · External reference
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
10.1093/nar/gkab382 · 2021 · External reference
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
10.1126/science.1082889 · 2003 · External reference
Mitochondrial dysfunction, oxidative stress, and neuroinflammation: Intertwined roads to neurodegeneration
10.3390/antiox9080647 · 2020 · External reference
Diabetes and Alzheimer's disease: might mitochondrial dysfunction help deciphering the common path?
10.3390/antiox10081257 · 2021 · External reference
The human serum metabolome
10.1371/journal.pone.0016957 · 2011 · External reference
Glutamate transporters and mitochondria: signaling, co-compartmentalization, functional coupling, and future directions
10.1007/s11064-020-02974-8 · 2020 · External reference
A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease
10.1016/j.neuint.2010.04.001 · 2010 · External reference
Metabolic perspective of astrocyte dysfunction in Alzheimer's disease and type 2 diabetes brains
10.1016/j.biopha.2022.114206 · 2023 · External reference
How does diabetes accelerate Alzheimer disease pathology?
10.1038/nrneurol.2010.130 · 2010 · External reference
Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: a meta-analysis of in vivo magnetic resonance spectroscopy studies
10.1016/j.arr.2021.101503 · 2021 · External reference
Risk factors for cognitive impairment in patients with type 2 diabetes
10.1155/2020/4591938 · 2020 · External reference
Glucose, glycolysis, and neurodegenerative diseases
10.1002/jcp.29682 · 2020 · External reference
Differential roles of M1 and M2 microglia in neurodegenerative diseases
10.1007/s12035-014-9070-5 · 2016 · External reference
An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases
10.3390/ijms23115938 · 2022 · External reference
Plasma metabolite profiles of Alzheimers disease and mild cognitive impairment
10.1021/pr5000895 · 2014 · External reference
Behavioral and neurochemical effects of proline
10.1007/s11011-011-9246-x · 2011 · External reference
Accelerated progression from mild cognitive impairment to dementia in people with diabetes
10.2337/db10-0539 · 2010 · External reference
The role of the GABAergic system in diseases of the central nervous system
10.1016/j.neuroscience.2021.06.037 · 2021 · External reference
Metabonomic profiles delineate potential role of glutamate-glutamine cycle in db/db mice with diabetes-associated cognitive decline
10.1186/s13041-016-0223-5 · 2016 · External reference
Glutamate as a neurotransmitter in the healthy brain
10.1007/s00702-014-1180-8 · 2014 · External reference
